Course 1 of 5

Longevity Fundamentals

The complete foundation. Seven lessons that teach you how aging works at the biological level, which biomarkers actually matter, and how to evaluate the evidence behind every longevity claim.

📖 7 lessons ⏱ ~45 minutes 📊 Beginner 🔓 100% free
Lesson 1 of 7

What Is Longevity Science?

Beyond "Anti-Aging"

Longevity science isn't about chasing immortality or reversing wrinkles. It's the evidence-based study of why organisms age and what can be done to extend healthspan — the years you live in good health, free from chronic disease and functional decline.

The distinction between lifespan (total years alive) and healthspan (years in good health) is the central insight of modern longevity research. A person who lives to 90 but spends the last 15 years with dementia, heart failure, and limited mobility has a lifespan of 90 but a healthspan closer to 75. The goal of longevity science is to close that gap.

Why Now?

Three developments have transformed longevity from fringe speculation to mainstream science:

  • Epigenetic clocks: models that estimate age from DNA methylation. The first multi-tissue clock, published in 2013, was built from 8,000 samples across 51 tissues and cell types.[1]
  • The hallmarks of aging: a 2013 review proposed nine common denominators of aging, expanded to twelve in 2023, as a map of where interventions might act.[2,3]
  • Clinical translation: drugs developed for other conditions are being studied for their effects on aging itself; a trial of metformin for that purpose (TAME) was proposed in 2016.[4]
Key Concept

Healthspan vs. lifespan. Modern longevity science focuses on extending the period of life spent in good health — not just adding years at the end. Every intervention is evaluated by whether it compresses morbidity (delays disease onset) or simply extends survival.

The Longevity Landscape

The field today spans multiple disciplines: molecular biology, gerontology, pharmacology, exercise physiology, nutrition science, and behavioral psychology. The most promising interventions range from zero-cost lifestyle modifications (exercise, sleep optimization) to experimental pharmaceuticals (senolytics, epigenetic reprogramming).

What makes IQ Healthspan different from most longevity resources: we grade the evidence. Not all interventions are equal. Some have decades of human data. Others have only mouse studies. Throughout this course, you'll learn to distinguish between them.

🧬
Hallmarks of Aging Explorer
Explore the 12 biological processes that drive aging
→
Knowledge Check
What is the primary distinction that defines modern longevity science?
Maximizing total lifespan regardless of health quality
Extending healthspan — the years lived in good health
Reversing visible signs of aging like wrinkles and gray hair
Replacing conventional medicine with supplements
Correct. Longevity science focuses on healthspan — compressing the period of morbidity at the end of life so that more years are spent in good physical and cognitive health.
Lesson 2 of 7

The 12 Hallmarks of Aging

A Roadmap for Understanding Aging

In 2013, López-Otín, Blasco, Partridge, Serrano and Kroemer proposed nine hallmarks of aging: common denominators of aging across organisms.[2] A 2023 update expanded the list to twelve: genomic instability, telomere attrition, epigenetic alterations, loss of proteostasis, disabled macroautophagy, deregulated nutrient-sensing, mitochondrial dysfunction, cellular senescence, stem cell exhaustion, altered intercellular communication, chronic inflammation and dysbiosis.[3] The framework is a map for research into why we age and where interventions might act.

Three Groups

The reviews sort the hallmarks into three groups:

Primary hallmarks (the initial damage): genomic instability, telomere attrition, epigenetic alterations, loss of proteostasis and disabled macroautophagy. These are damage to DNA, chromosome ends, gene regulation, and the systems that keep proteins in order and recycle worn-out cell parts.

Antagonistic hallmarks (the body's response): deregulated nutrient sensing, mitochondrial dysfunction, and cellular senescence. Initially protective, these responses become harmful over time.

Integrative hallmarks (the consequences): stem cell exhaustion, altered intercellular communication, chronic inflammation and dysbiosis. These emerge when damage builds up faster than repair can keep pace.

Why This Matters

Interventions are often described by the hallmark they target: rapamycin acts on nutrient sensing through mTOR, and senolytics are drugs designed to clear senescent cells. Knowing the hallmarks helps you see what a claim is really about, and whether there is human evidence behind it.

The Interconnection Problem

No hallmark operates in isolation: genomic damage, mitochondrial dysfunction, senescence and inflammation feed into one another. The original review named untangling those connections, and each hallmark's contribution to aging, as a major open challenge.[2]

🔬
Interactive Hallmarks Explorer
Click each hallmark to see the human studies that have tested it
→
Knowledge Check
Which category do cellular senescence and mitochondrial dysfunction belong to?
Primary hallmarks — the initial damage
Antagonistic hallmarks — initially protective responses that become harmful
Integrative hallmarks — the downstream consequences
They belong to different categories
Correct. Antagonistic hallmarks are responses that are beneficial in moderation but become damaging over time. Cellular senescence initially prevents cancer by stopping damaged cells from dividing, but accumulated senescent cells release inflammatory signals. Mitochondrial dysfunction triggers stress responses that are protective short-term but harmful chronically.
Lesson 3 of 7

Biological vs. Chronological Age

Your Birthday Isn't Your Real Age

Chronological age is how many years since you were born. Biological age is how old your body actually is at the cellular and molecular level. Two 50-year-olds can have dramatically different biological ages — one might have the biology of a 40-year-old, the other of a 60-year-old — based on genetics, lifestyle, environment, and cumulative health decisions.

How Biological Age Is Measured

Epigenetic clocks are the best-known measures. These algorithms read DNA methylation patterns at specific sites across the genome. Widely used clocks include:

  • Horvath clock: the original multi-tissue clock (2013), which estimates DNA methylation age in most tissues and cell types[1]
  • GrimAge: built to predict time to death from DNA methylation stand-ins for seven plasma proteins and for smoking pack-years[5]
  • DunedinPACE: measures the pace of aging, distilled from two decades of decline in 19 indicators of organ-system integrity in a New Zealand birth cohort[6]

DunedinPACE was designed to track change. In the CALERIE trial, 220 adults randomized to two years of calorie restriction slowed their DunedinPACE, while PhenoAge and GrimAge did not change significantly.[7]

Key Concept

Rate of aging vs. total biological age. DunedinPACE expresses aging as a rate: higher values mean faster biological aging and lower values slower. That design makes it a candidate for tracking interventions, though no clock is yet a validated target for treatment.

Other Assessment Methods

Simple physical measures also track aging and survival. In pooled data from 34,485 adults aged 65 or older, each 0.1 m/s faster walking speed went with lower mortality (hazard ratio 0.88),[8] and each 5 kg lower grip strength went with higher mortality.[9]

⏱
Biological Age Calculator
Estimate PhenoAge from nine blood tests, or try the lifestyle questionnaire
→
Knowledge Check
What distinguishes DunedinPACE from older epigenetic clocks like Horvath?
It uses more DNA methylation sites for greater accuracy
It requires a blood sample rather than saliva
It measures the current rate of aging rather than cumulative biological age
It's the only clock validated in large human studies
Correct. DunedinPACE measures how fast you are aging now. In the CALERIE trial, calorie restriction slowed DunedinPACE while older-style clock estimates such as GrimAge and PhenoAge did not change significantly.[7]
Lesson 4 of 7

The Biomarkers That Matter

Reference Ranges, Guideline Cut-offs and "Optimal" Claims

A lab's reference range describes the middle 95% of results in people the lab considers healthy. Clinical guidelines add cut-offs where risk or the need for treatment changes, such as an HbA1c of 5.7% (prediabetes) or 6.5% (diabetes).[10] Many longevity sources go further and publish tighter "optimal" ranges, but for most markers no guideline defines one. This course uses guideline categories and says when a marker has no agreed cut-off.

The Core Panel

If you could only track a handful of biomarkers, these are a sensible start:

  • LDL cholesterol: the main target of cholesterol treatment. Under 100 mg/dL is the healthy level for adults,[11] and at 190 mg/dL or higher US guidelines recommend statin treatment without a separate risk calculation,[12] a rule the 2026 guideline kept (ACC, September 2026).
  • ApoB: counts atherogenic particles and can capture risk that LDL cholesterol misses when the two disagree. There is no single cut-off; how to read it depends on your overall risk.
  • Lp(a): more than 90% inherited, so a European consensus panel recommends measuring it at least once in adulthood; above 50 mg/dL (125 nmol/L) is high.[13]
  • HbA1c: average blood sugar over about three months. Under 5.7% is normal, 5.7–6.4% is the prediabetes range and 6.5% or higher is the diabetes range.[10]
  • Fasting insulin: rises with insulin resistance, but there is no agreed cut-off, so it is most useful tracked over time alongside glucose.
  • hsCRP: an inflammation marker used to refine cardiovascular risk. Under 1 mg/L is low risk, 1–3 is average and above 3 is high.[14]
Evidence Note

Each category above is cited to a clinical guideline or an NIH reference page. When a source defines no cut-off, as for ApoB in the general population or fasting insulin, we say so rather than invent one.

Beyond Blood

Some informative markers are not in a blood draw. Among adults referred for treadmill testing, the mortality risk linked to low cardiorespiratory fitness was comparable to or greater than that of smoking or diabetes.[15] Each 5 kg lower grip strength was linked to higher mortality (hazard ratios 1.20 in women and 1.16 in men),[9] and European guidance treats low muscle strength as the key feature of sarcopenia.[16] Walking speed predicts survival in older adults.[8]

📊
Biomarker Reference Guide
What key markers measure and how to read them
→
Knowledge Check
In a large treadmill-testing study, which measure was linked to mortality as strongly as, or more strongly than, smoking or diabetes?
HbA1c (blood sugar control)
ApoB (cardiovascular lipid marker)
Cardiorespiratory fitness (VO₂ max)
hsCRP (systemic inflammation)
Correct. Among adults referred for treadmill testing, mortality fell with each step up in fitness: the fittest had 80% lower risk than the least fit (hazard ratio 0.20), and the risk linked to low fitness was comparable to or greater than that of smoking or diabetes.[15]
Lesson 5 of 7

The Evidence Hierarchy

Not All Evidence Is Equal

The longevity space is flooded with claims. Supplement companies cite mouse studies as proof their product extends lifespan. Biohackers present n=1 experiments as science. Podcasters interview researchers and turn preliminary findings into definitive recommendations. To navigate this landscape, you need to understand how evidence is ranked.

The Hierarchy

From strongest to weakest:

  1. Systematic reviews and meta-analyses: combine the results of multiple studies and are traditionally placed at the top of the evidence pyramid.[17]
  2. Randomized controlled trials (RCTs) — gold standard for causation. Participants are randomly assigned to treatment or control groups.
  3. Prospective cohort studies — follow large groups over time. Strong for identifying associations, but can't prove causation.
  4. Mendelian randomization studies — use genetic variants as natural experiments to infer causal relationships. Increasingly important in longevity science.
  5. Cross-sectional and case-control studies — useful for generating hypotheses but vulnerable to confounding variables.
  6. Animal studies — essential for early-stage research but often fail to translate to humans. A compound that extends mouse lifespan may do nothing in humans.
  7. In vitro (cell culture) studies — the earliest stage. Useful for understanding mechanisms, not for clinical decisions.
  8. Expert opinion and anecdotal evidence — the lowest tier. "It works for me" is data, but it's the weakest kind.
Key Concept

The translation gap. A compound that works in mice or cell cultures may not work in humans, and most drug candidates that reach human trials never win approval: in an analysis of trial data on more than 21,000 compounds, cancer drugs succeeded only 3.4% of the time.[18] When you see a longevity claim, always ask: "Is this from human data, animal data, or cell data?"

IQH's Evidence Grading

In the Supplement Evidence Database, each grade applies to a stated outcome and reflects randomized trials in people: A means consistent trial evidence for the stated benefit; B means benefits on intermediate measures such as blood pressure, or limited benefits on outcomes; C means mostly animal or laboratory evidence, or small, short or conflicting human trials; and D means well-designed trials found no benefit for the main promoted use, or found harm. No supplement has been shown to slow human aging itself.

📋
Supplement Evidence Database
Counted evidence for 25 compounds, each tied to a stated outcome
→
Knowledge Check
A supplement company claims their product "extends lifespan by 20%." The study was conducted in mice. What should your primary concern be?
Mouse studies are unreliable in general
Mouse results often fail to carry over to people (the translation gap)
The study was probably funded by the supplement company
Lifespan extension in mice is typically exaggerated by researchers
Correct. The translation gap is the most critical concept. Funding conflicts and researcher bias are real concerns, but the basic problem is that results in mice often fail to carry over to people, and most drug candidates that reach human trials never win approval.[18]
Lesson 6 of 7

The Five Pillars of Longevity

The Foundation Before Supplements

Lifestyle has the strongest evidence of anything in this field. In a US analysis, adults with all five low-risk lifestyle factors were projected to live 14 years longer from age 50 if women, and 12.2 years longer if men, than adults with none.[19] Supplement trials have mostly disappointed by comparison: in the VITAL trial, vitamin D did not lower the incidence of cancer or cardiovascular events.[20]

Pillar 1: Exercise

The dose-response evidence is strong. Compared with no leisure-time activity, doing one to two times the guideline minimum was linked to 31% lower mortality, with a modest further gain at higher volumes (39%).[21] In accelerometer studies, the most active quarter of people had about a quarter of the mortality risk of the least active (hazard ratio 0.27),[22] and higher activity was linked to lower risk of 13 types of cancer.[23] US guidelines call for 150 to 300 minutes a week of moderate activity, or 75 to 150 minutes of vigorous activity, plus muscle-strengthening on two or more days.[24]

Pillar 2: Sleep

Adults are advised to sleep seven to nine hours a night, and older adults seven to eight.[25] In a meta-analysis of prospective studies, short sleep was associated with a 12% higher risk of death and long sleep with a 30% higher risk.[26] In mice, sleep enlarged the space between brain cells by 60% and sped the clearance of β-amyloid, a finding not yet shown to work the same way in people.[27]

Pillar 3: Nutrition

Protein needs rise with age: an expert group recommends at least 1.0 to 1.2 g per kilogram of body weight a day for adults over 65,[28] and with resistance training, intakes above about 1.6 g/kg a day added no further muscle in a meta-analysis.[29] An umbrella review found convincing evidence linking more ultra-processed food to higher cardiovascular mortality.[30] Time-restricted eating on its own was no better for weight loss than eating throughout the day in a 12-week trial.[31]

Pillar 4: Stress Management

Chronic stress shows up in the body: women with the highest perceived stress had telomeres shorter by the equivalent of at least a decade of extra aging compared with women with low stress.[32] Which stress-reduction methods change long-term health outcomes is less certain.

Pillar 5: Social Connection

In a meta-analysis of 148 studies, people with stronger social relationships had 50% higher odds of survival.[33] A later meta-analysis linked loneliness, social isolation and living alone to higher mortality (odds ratios 1.26, 1.29 and 1.32).[34]

Key Concept

Habits first. The largest, best-supported gains come from activity, sleep, diet, not smoking and the other everyday habits. Supplements and drugs come after those, and most have far weaker evidence. That is why this course covers the pillars before any discussion of compounds.

📈
Longevity Score Assessment
Rate yourself across 10 dimensions including all five pillars — see where to focus
→
Knowledge Check
Which statement about the five pillars is best supported by current evidence?
Supplements can compensate for poor sleep and exercise habits
Nutrition is the most impactful pillar, with exercise in second place
Healthy habits are linked to many extra years of life, while supplement trials have mostly found no prevention benefit
Social connection matters but isn't supported by mortality data
Correct. In a US analysis, adults with five low-risk habits were projected to live 12 to 14 more years from age 50 than adults with none,[19] while large supplement trials such as VITAL found no reduction in cancer or cardiovascular events.[20]
Lesson 7 of 7

Building Your Starting Point

From Knowledge to Action

You now have the conceptual framework: the hallmarks of aging explain why we age, biological age tells you where you stand, biomarkers show what to track, evidence grades tell you what to trust, and the five pillars show you where to start. The final step is translating this into a personal starting point.

Step 1: Establish Your Baseline

Before optimizing anything, you need to know where you are. Start with IQ Healthspan's free tools:

  • Take the Biological Age Calculator for a lifestyle-based estimate
  • Take the Longevity Score assessment to see which of the 10 dimensions needs the most attention
  • If you are due for bloodwork, the Blood Panel Builder sorts tests by how strongly guidelines support them. US guidance finds insufficient evidence to screen symptom-free adults for vitamin D deficiency.[35]

Step 2: Identify Your Weakest Pillar

Rather than trying to optimize everything simultaneously, identify the single pillar where you have the most room for improvement. If you're not exercising at all, that's your highest-leverage starting point. If you're sleeping 5 hours a night, sleep comes first. Improving your weakest pillar produces the greatest marginal return.

Step 3: Start Small, Track Consistently

Evidence-based longevity is a decades-long practice. Start with sustainable changes you can keep for years, not extreme protocols you will abandon in weeks. Retest when your clinician advises, and use the Dashboard tool to see trends over time.

Key Concept

The first steps matter most. In accelerometer studies, moving from the least active quarter of people to the next was linked to about half the mortality risk (hazard ratio 0.48), a bigger step than any that followed.[22]

Where to Go Next

This course gave you the foundation. From here, you can deepen your knowledge in specific areas:

  • Course 2: Optimize Your Bloodwork — learn exactly which tests to order, and how to interpret them against guideline ranges
  • Course 3: Build Your First Protocol — design a personalized, evidence-based protocol using the Protocol Builder
  • Course 4: Sleep Optimization — deep-dive into sleep architecture, circadian biology, and evidence-rated interventions
  • Course 5: Exercise for Longevity — the complete exercise protocol with Zone 2, VO₂ max, and resistance training
✅
Longevity Score Assessment
Find your weakest pillar — 40-question assessment across 10 dimensions
→
⏱
Biological Age Calculator
Establish your baseline biological age estimate
→
Knowledge Check
What's the most effective approach when starting a longevity protocol?
Implement as many interventions as possible for maximum coverage
Identify your weakest pillar and make sustainable improvements there first
Start with the most advanced interventions for the greatest impact
Focus exclusively on bloodwork optimization before anything else
Correct. Improving your weakest pillar gives the greatest return. In pooled cohort data, the steepest drop in mortality risk came between the least active people and the next group up.[22] Sustainable changes beat extreme protocols.

References

  1. 1Horvath S. "DNA methylation age of human tissues and cell types." Genome Biol. 2013;14(10):R115. PubMed · DOI
  2. 2López-Otín C, et al. "The hallmarks of aging." Cell. 2013;153(6):1194-217. PubMed · DOI
  3. 3López-Otín C, et al. "Hallmarks of aging: An expanding universe." Cell. 2023;186(2):243-278. PubMed · DOI
  4. 4Barzilai N, et al. "Metformin as a Tool to Target Aging." Cell Metab. 2016;23(6):1060-1065. PubMed · DOI
  5. 5Lu AT, et al. "DNA methylation GrimAge strongly predicts lifespan and healthspan." Aging (Albany NY). 2019;11(2):303-327. PubMed · DOI
  6. 6Belsky DW, et al. "DunedinPACE, a DNA methylation biomarker of the pace of aging." Elife. 2022;11. PubMed · DOI
  7. 7Waziry R, et al. "Effect of long-term caloric restriction on DNA methylation measures of biological aging in healthy adults from the CALERIE trial." Nat Aging. 2023;3(3):248-257. PubMed · DOI
  8. 8Studenski S, et al. "Gait speed and survival in older adults." JAMA. 2011;305(1):50-8. PubMed · DOI
  9. 9Celis-Morales CA, et al. "Associations of grip strength with cardiovascular, respiratory, and cancer outcomes and all cause mortality: prospective cohort study of half a million UK Biobank participants." BMJ. 2018;361:k1651. PubMed · DOI
  10. 10MedlinePlus (US National Library of Medicine). "Hemoglobin A1C (HbA1c) Test." Accessed October 1, 2026. Source
  11. 11MedlinePlus (US National Library of Medicine). "Cholesterol Levels: What You Need to Know." Accessed October 1, 2026. Source
  12. 12Grundy SM, et al. "2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines." Circulation. 2019;139(25):e1082-e1143. PubMed · DOI
  13. 13Kronenberg F, et al. "Lipoprotein(a) in atherosclerotic cardiovascular disease and aortic stenosis: a European Atherosclerosis Society consensus statement." Eur Heart J. 2022;43(39):3925-3946. PubMed · DOI
  14. 14Pearson TA, et al. "Markers of inflammation and cardiovascular disease: application to clinical and public health practice: A statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association." Circulation. 2003;107(3):499-511. PubMed · DOI
  15. 15Mandsager K, et al. "Association of Cardiorespiratory Fitness With Long-term Mortality Among Adults Undergoing Exercise Treadmill Testing." JAMA Netw Open. 2018;1(6):e183605. PubMed · DOI
  16. 16Cruz-Jentoft AJ, et al. "Sarcopenia: revised European consensus on definition and diagnosis." Age Ageing. 2019;48(1):16-31. PubMed · DOI
  17. 17Murad MH, et al. "New evidence pyramid." Evid Based Med. 2016;21(4):125-7. PubMed · DOI
  18. 18Wong CH, et al. "Estimation of clinical trial success rates and related parameters." Biostatistics. 2019;20(2):273-286. PubMed · DOI
  19. 19Li Y, et al. "Impact of Healthy Lifestyle Factors on Life Expectancies in the US Population." Circulation. 2018;138(4):345-355. PubMed · DOI
  20. 20Manson JE, et al. "Vitamin D Supplements and Prevention of Cancer and Cardiovascular Disease." N Engl J Med. 2019;380(1):33-44. PubMed · DOI
  21. 21Arem H, et al. "Leisure time physical activity and mortality: a detailed pooled analysis of the dose-response relationship." JAMA Intern Med. 2015;175(6):959-67. PubMed · DOI
  22. 22Ekelund U, et al. "Dose-response associations between accelerometry measured physical activity and sedentary time and all cause mortality: systematic review and harmonised meta-analysis." BMJ. 2019;366:l4570. PubMed · DOI
  23. 23Moore SC, et al. "Association of Leisure-Time Physical Activity With Risk of 26 Types of Cancer in 1.44 Million Adults." JAMA Intern Med. 2016;176(6):816-25. PubMed · DOI
  24. 24Piercy KL, et al. "The Physical Activity Guidelines for Americans." JAMA. 2018;320(19):2020-2028. PubMed · DOI
  25. 25Hirshkowitz M, et al. "National Sleep Foundation's updated sleep duration recommendations: final report." Sleep Health. 2015;1(4):233-243. PubMed · DOI
  26. 26Cappuccio FP, et al. "Sleep duration and all-cause mortality: a systematic review and meta-analysis of prospective studies." Sleep. 2010;33(5):585-92. PubMed · DOI
  27. 27Xie L, et al. "Sleep drives metabolite clearance from the adult brain." Science. 2013;342(6156):373-7. PubMed · DOI
  28. 28Bauer J, et al. "Evidence-based recommendations for optimal dietary protein intake in older people: a position paper from the PROT-AGE Study Group." J Am Med Dir Assoc. 2013;14(8):542-59. PubMed · DOI
  29. 29Morton RW, et al. "A systematic review, meta-analysis and meta-regression of the effect of protein supplementation on resistance training-induced gains in muscle mass and strength in healthy adults." Br J Sports Med. 2018;52(6):376-384. PubMed · DOI
  30. 30Lane MM, et al. "Ultra-processed food exposure and adverse health outcomes: umbrella review of epidemiological meta-analyses." BMJ. 2024;384:e077310. PubMed · DOI
  31. 31Lowe DA, et al. "Effects of Time-Restricted Eating on Weight Loss and Other Metabolic Parameters in Women and Men With Overweight and Obesity: The TREAT Randomized Clinical Trial." JAMA Intern Med. 2020;180(11):1491-1499. PubMed · DOI
  32. 32Epel ES, et al. "Accelerated telomere shortening in response to life stress." Proc Natl Acad Sci U S A. 2004;101(49):17312-5. PubMed · DOI
  33. 33Holt-Lunstad J, et al. "Social relationships and mortality risk: a meta-analytic review." PLoS Med. 2010;7(7):e1000316. PubMed · DOI
  34. 34Holt-Lunstad J, et al. "Loneliness and social isolation as risk factors for mortality: a meta-analytic review." Perspect Psychol Sci. 2015;10(2):227-37. PubMed · DOI
  35. 35Krist AH, et al. "Screening for Vitamin D Deficiency in Adults: US Preventive Services Task Force Recommendation Statement." JAMA. 2021;325(14):1436-1442. PubMed · DOI